Cargando…
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
As the major nonpsychotropic constituent of Cannabis sativa, cannabidiol (CBD) is regarded as one of the most promising therapeutic agents due to its proven effectiveness in clinical trials for many human diseases. Due to the urgent need for more efficient pharmacological treatments for several chro...
Autores principales: | Ożarowski, Marcin, Karpiński, Tomasz M., Zielińska, Aleksandra, Souto, Eliana B., Wielgus, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122338/ https://www.ncbi.nlm.nih.gov/pubmed/33919010 http://dx.doi.org/10.3390/ijms22094294 |
Ejemplares similares
-
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review
por: Zielińska, Aleksandra, et al.
Publicado: (2023) -
Plant Phenolics and Extracts in Animal Models of Preeclampsia and Clinical Trials—Review of Perspectives for Novel Therapies
por: Ożarowski, Marcin, et al.
Publicado: (2021) -
Molecular and Cellular Mechanisms of Action of Cannabidiol
por: Martinez Naya, Nadia, et al.
Publicado: (2023) -
Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
por: Zielińska, Aleksandra, et al.
Publicado: (2022) -
The Effects of Propolis on Viral Respiratory Diseases
por: Ożarowski, Marcin, et al.
Publicado: (2023)